Blood-brain barrier permeability regulating agent and application thereof

The invention relates to application of SC79 or analogues thereof in preparation of a blood-brain barrier permeability regulating agent. The blood-brain barrier permeability regulating agent takes SC79 or an analogue thereof as an effective component; by activating Claudin-5 and Occludin signal path...

Full description

Saved in:
Bibliographic Details
Main Authors WANG KAI, HU FUQIANG, MENG TINGTING, YUAN HONG, WEN LIJUAN
Format Patent
LanguageChinese
English
Published 04.08.2020
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:The invention relates to application of SC79 or analogues thereof in preparation of a blood-brain barrier permeability regulating agent. The blood-brain barrier permeability regulating agent takes SC79 or an analogue thereof as an effective component; by activating Claudin-5 and Occludin signal paths at the downstream of the protein kinase B, the expression of the closely linked proteins Claudin-5and Occludin is reduced, and the expression of the Occludin is reduced. Therefore, the blood-brain barrier permeability is improved, the brain-entering transport efficiency of the brain-targeted drugdelivery system is enhanced, and especially, the brain-entering transport efficiency of the Angiopep-2 modified glycolipid nano-drug delivery system can be enhanced. The invention also relates to a kit, which comprises the blood-brain barrier permeability regulating agent and a brain-targeted drug delivery system. According to the invention, the blood-brain barrier permeability regulating agent and the brain-targeted drug
Bibliography:Application Number: CN201910073172